Celecoxib may be effective in preventing non-melanoma skin cancers

Celecoxib may help prevent nonmelanoma skin cancers in patients with extensive actinic keratosis, which is often a precursor to these cancers, according to a randomized clinical trial published online November 29 in The Journal of the National Cancer Institute.

Read the whole article on Physorg

More from Physorg